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Introduction: Currently, there are over a million individuals living with HIV in North 
America, with over one-third not in HIV primary care and twice as many reporting 
cigarette smoking as non-HIV-infected individuals. Few smoking cessation programs 
exist to target this population and little research has been focused on the relationship 
between smoking and retention in care.  The objectives were to describe patterns of 
smoking in HIV-infected adults by demographic characteristics and to estimate the 
association of smoking on failing to be retained in HIV primary care.   
Methods: Analysis included data from five clinical cohorts from the North American 
Cohort Collaboration on Research and Design (NA-ACCORD).  Adults retained in care 
during the year of their first visit and who contributed laboratory and smoking data for at 
least two visits from 2008 to 2010 were analyzed.  Smoking status was time-varying and 
defined as never, ever, or current.  Retention in care was defined as ≥2 HIV primary care 
visits ≥90 days apart in a calendar year.  Trends in smoking statuses were described by 
characteristics such as age, sex, race, injection drug use (IDU), region of residence, and 
highly active antiretroviral therapy (HAART) use.  Trends in the proportions of 
never/ever/current smokers were detected using logistic regression models with 
generalized estimating equations (GEE) using independent correlation matrixes and 
robust variance estimations. Univariate and multivariate Cox proportional hazard models 
with the Efron method for ties were used to assess associations between time-varying 
smoking status and failing to be retained in HIV primary care over the study period.   
Results: The sample of 3,575 HIV+ participants were 74% male, 47% African American, 
19% IDUs, and 62% Southern US residents.  At baseline, 28% were current smokers, 




43% ever smokers, and 28% never smokers. 17% of the NA-ACCORD population failed 
to be retained in care from 2008 to 2010, with a reduced risk among ever smokers (vs. 
never) (aHR=0.64 [0.50, 0.81]) and no difference in risk among current smokers and 
never smokers (aHR=0.92 [0.73, 1.17]) adjusting for characteristics.  
Conclusions:  Programs incorporating smoking cessation into HIV clinical care may help 
better retain current smokers who are trying to quit.   
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Chapter 1: Introduction 
Currently, there are an estimated 1.3 million individuals living with HIV in North 
America (1).  Approximately 40 to 63% of HIV-infected adults smoke cigarettes (2-4) 
with an average consumption of 16-23 cigarettes per day (5 & 6) and an average duration 
of 22.8 years (7).  According to the CDC, tobacco use is the leading cause of preventable 
disease, disability, and death in the United States and is strongly associated with 
decreased quality of life and increased mortality among HIV-infected adults (4 & 8).    
Even with viral control, HIV-infected adults who smoke have an increased risk for 
cardiovascular disease, cancer, and pulmonary diseases (9-11).  HIV-infection further 
increases the susceptibility of smokers to chronic obstructive pulmonary disease (COPD), 
lung, head, and neck cancers (2, 4, 12-14), and respiratory infections such as bacterial 
pneumonia (16 & 17) and tuberculosis (15).  De and colleagues reported a 70 to 100% 
increased risk of bacterial pneumonia in HIV-infected smokers and cessation reduced the 
risk of bacterial pneumonia by roughly 27% (16). HIV-infected smokers also report a 
substantially decreased quality of life (4), lower general health perception, physical 
functioning, bodily pain, energy, and cognitive functioning compared to HIV-infected 
non-smokers (17).  HIV-infected individuals who smoke were more likely to complain of 
cough, shortness of breath, wheezing, or chest pain compared to HIV-infected non-
smokers (17).  Smokers with newly diagnosed HIV-infection are more likely to have a 
lower CD4 cell count at ART initiation and mount a reduced response to ART compared 
to newly-diagnosed HIV-infected non-smokers (18 & 19).   
1.1 Correlates of cigarette smoking in HIV-infected adults 
Among those living with HIV, individuals who reported ever smoking were more 




likely to be older (7 & 20), non-white (17, 21, 22), and report greater injection drug use 
and alcohol consumption compared to HIV-infected individuals who reported never 
smoking (4, 7, 17, 20, 22).  The Swiss HIV Cohort Study reported that the majority of 
persons living with HIV up to 64 years of age are more likely to identify as current 
smokers compared with former smokers and never smokers, while HIV-infected persons 
older than 65 years of age are more likely to identify as never smokers (9).  Recent 
studies have also reported conflicting results on whether ever smokers compared to never 
smokers are more likely to be male (20) or female (17).  The HIV-infected study 
population that produce these results must be carefully considered, as the HIV-infected 
population is likely heterogeneous in demographics related to smoking, for example 
affluent white men who have sex with men (MSM) and lower socioeconomic status 
women of color.  
1.2 Retention in HIV primary care 
 Immediately linking HIV-positive persons to continuous primary care is one of 
the key goals of the 2010 US National HIV/AIDS Strategy.  There is no gold standard of 
measuring retention in HIV care, however, similar estimates of retention are found by 
measuring gaps in care, visit constancy, and Health Resources and Service 
Administration (HRSA) medical visit criteria (23).  Long-term retention in care has been 
associated with timely reception of antiretroviral therapy, increased virologic control (24-
26), and decreased race/ethnicity-related healthcare disparities among African Americans 
(27).  Characteristics of HIV-infected individuals with poor retention in care include 
younger age, non-White race/ethnicity, greater alcohol and illicit drug use, higher CD4 
count, and greater hepatitis C virus coinfection (29-35).  Conversely, having a chronic 




medical comorbidity, using HAART, and being identified in as having MSM 
transmission risk were associated with better retention in care (30).  Failing to be retained 
in HIV primary care, particularly in the first year post-HIV diagnosis, has been associated 
with adverse HIV-related outcomes and increased long-term mortality (28).        
1.3 Cigarette smoking and retention in HIV primary care 
Although approximately 36% to 50% of HIV-infected individuals are not in routine 
care (29, 36, 37), little research has been focused on the relationship between cigarette 
smoking and retention in HIV primary care.  Hessol et al. investigated whether cigarette 
smoking was associated with retention and attendance of women enrolled in the 
Women’s Interagency HIV Study (WIHS) (38).  This study investigated demographic 
factors associated with poor early and later retention including cigarette smoking history.  
Predictors of retention include older age, White race, higher CD4 cell count, and lower 
HIV viral load.  Cigarette smoking was not found to be a significant predictor of 
retention.  The authors utilized a time-varying approach to capture predictors in retention 
and the study population was limited to women, the majority of whom were women of 
color and of lower socioeconomic status. 
In general, HIV-infected substance users may be less likely to have an HIV-care 
provider or to be receiving HAART (39), more likely to use emergency department 
services (39), and have worse early retention in HIV care (33 & 38). Poor early retention 
in care is associated with Black race/ethnicity, hepatitis C infection, substance use, 
younger age, having a primary care provider, geographic location, and a higher viral load 
(29, 30, 33, 38, & 41).  However, studies have conflicting results on whether lower (38) 
or higher CD4 cell counts (30 & 33) are associated with poor early retention in care.  In 




addition, studies on retention in care have used undefined terms such as “substance 
abusers” or “substance users” without specifying whether cigarette smokers are included 
in this subgroup (33).   
Although there are limited studies of cigarette smoking and retention in HIV primary 
care, recent publications have highlighted a significant relationship between smoking and 
ART nonadherence (42 & 43).  Using self-administered medical questionnaires to assess 
HAART adherence, Spire et al.’s 2002 study identified several factors associated with 
poor adherence:  younger age, poor housing conditions, lack of social support, and 
previous history of poor adherence to ART regimens.  Furthermore, the authors found 
non-adherence associated with dynamic characteristics of patients not easily identifiable 
by clinicians before prescription of ART: depression, symptoms associated with 
treatment side effects, perception of health status, beliefs toward HAART effectiveness 
and toxicity, alcohol consumption, and cigarette smoking (44).  Patients who increased 
their smoking consumption from HAART-initiation and those who maintained a heavy 
consumption of cigarettes were more likely to be non-adherent to HAART at the four 
month follow-up visit.   
Similarly, Shuter & Bernstein conducted an ART adherence study using the 
Medication Event Monitoring System and found current smoking, but not former 
smoking, to be a significant factor of poor ART adherence compared to non-smokers 
(45).  This relationship may be explained by multiple drug use, such as cigarette smoking 
with alcohol abuse or injection drug use (42), or by depression (43).   
1.4 Tobacco cessation interventions targeting HIV-infected individuals 
Despite the association between cigarette smoking and non-adherence in ART use 




in HIV-infected individuals, few smoking cessation programs exist to target this 
population.  We are aware of only two publications reporting findings from smoking 
cessation trials targeting HIV-infected persons (46-48, 49).  These findings suggest that 
cessation treatments can significantly reduce smoking rates among HIV-infected persons.  
Although smoking cessation trials targeting HIV-infected persons are lacking, there is a 
high self-reported desire among HIV-infected smokers to quit smoking, with significant 
interest and adherence in smoking cessation services and programs (7, 46-48, 50, & 51).   
The objective of this thesis is two-fold: 
1. to describe patterns of cigarette smoking in HIV-infected adults by demographic 
characteristics; and  
2. to estimate the association of cigarette smoking on failing to be retained in HIV 
primary care.   
Smoking habits can change over time, requiring a time-varying approach to most 
accurately capture cigarette smoking patterns over time.  Using a time-fixed approach to 
measure cigarette smoking can contribute to imprecise estimated proportions of HIV-
infected persons who smoke (7, 20, & 52).  Findings of this study could serve to further 
emphasize smoking cessation efforts in HIV primary care.  Smoking cessation after entry 
into HIV primary care may be particularly important for successful smoking cessation 
and retention in long-term HIV management.   
  




Chapter 2: Methods 
2.1 Study design and population 
 The NA-ACCORD is a multi-site collaboration of interval and clinical cohort 
studies of HIV-infected adults (>18 years old) in the United States and Canada.  The NA-
ACCORD is one of the multi-national cohort collaborations sponsored by the National 
Institute of Health’s International Epidemiological Databases to Evaluate AIDS 
consortium.  Details on the NA-ACCORD collaboration have been published previously 
(53) and are regularly updated on their dossier (www.naaccord.org).  Participants in the 
NA-ACCORD were enrolled in previously-established contributing clinical and interval 
cohorts; participants in clinical cohorts were required to have 2 clinical visits within 12 
months and ≥90 days apart for enrollment. Cohorts contribute data on patient 
demographics, prescribed ART, dates of primary HIV clinical visits, clinical diagnoses, 
vital status, and results of laboratory tests (including HIV-1 RNA viral load). All data are 
transferred securely to the NA-ACCORD’s central Data Management Core (DMC, 
University of Washington), where they undergo quality control per a standardized 
protocol before they are combined into harmonized data files. Additional quality control 
measures are enforced on the data at the Epidemiology/Biostatistics Core (Johns Hopkins 
Bloomberg School of Public Health) prior to the creation of analytic data files. The 
activities of the NA-ACCORD have been reviewed and approved by the local 
institutional review boards for each site and at Johns Hopkins School of Medicine.  
 The NA-ACCORD data collected in calendar year 2011 (i.e. “Protocol 2011” or 
P2011) current as of October 9th, 2013, were used as the data source. Patients were 
selected into our nested study according to inclusion criteria outlined below.   




2.2 Inclusion criteria  
 At the cohort level, the analysis was limited to the six contributing NA-ACCORD 
clinical cohorts that had a median number of ≥2 reported smoking statuses for each 
individual. The six cohorts used were the HIV Research Network (HIVRN), the Johns 
Hopkins HIV Clinical Cohort (JHHCC), the Ontario HIV Treatment Network Cohort 
Study (OHTN), the Southern Alberta Clinic Cohort (SAC), the University of Alabama at 
Birmingham 1917 Clinic Cohort (UAB), and the University Of Washington HIV Cohort 
(UW).  These cohorts have sites in three US Census Bureau-designated regions 
(Northeast, South, and West) and four Canadian provinces and territories (Alberta, 
British Columbia, Ontario, and Saskatchewan). From this point forward, the cohorts were 
assigned numeric labels in efforts to conceal cohort-specific results. 
At the individual level, the analysis included only who had laboratory (either CD4 
count or HIV-1 viral load) and substance use survey data for at least two visits between 
January 1, 2008 and December 31, 2010; laboratory data were used to measure the 
outcome of interest (failure to be retained in care) and substance survey data were used to 
measure the exposure of interest (smoking status).  For Aim 2, patients were also required 
to be retained in care during the year of their first visit to ensure they were at risk for the 
outcome of interest. Cohort 3 was excluded from Aim 2 due to lack of HIV primary care 
data, which is needed to measure the outcome of retention in care.  
2.3 Outcome: Failure to be retained in care 
The outcome of interest was failing to be retained in care.  Participating cohorts 
provided information on HIV primary care visits; surrogates for retention in HIV care, 
such as CD4 count or HIV RNA measurements, were not used.  Retention in care was 




defined using the Institute of Medicine’s (IOM) retention in care definition: ≥2 HIV 
primary care visits ≥90 days apart in a calendar year (40).  Failing to be retained in care 
was identified as the last date at which an individual was meeting the definition of 
retained in care (a conservative approach). 
2.4 Exposure: Never/ever/current smoking status 
Smoking history was collected from cohorts using a substance survey that 
collected self-reported data.  Metadata describing the time frame during which a cohort 
collected substance survey data were used to determine the smoking status observation 
periods for each cohort; the smoking status periods for each cohort can be seen in Figure 
1.  
There was not a standardized substance survey data collection tool across the 
cohorts, rather, the NA-ACCORD DMC requested any and all smoking data collected by 
each cohort via any type of substance survey.  The DMC reviewed all cohort-specific 
data collection tools and mapped the smoking data from questions on the substance 
surveys into the following categories by cohort: current, current none, past, unspecified 
time frame, never, and not mapped.   For this nested study, if the NA-ACCORD 
substance use response code was classified as “current,” the time-varying smoking status 
for this patient at this time point is “current”.  If the response code was classified as 
past/unspecified time frame, the time-varying smoking status for this patient at this time 
point was classified as “ever”.  If the response code was classified as never, the time-
varying smoking status for this patient at this time point was classified as “never”.   
Smoking data were then systematically cleaned so that an individual reporting 
current or ever smoking could not subsequently report never smoking. Duplicate patient 




records with the same smoking status noted on the same day were omitted. If there were 
more than two responses on the same day the priority was given to current smoking 
status, followed by ever and then never.  
2.5 Potential confounders 
Factors (measured at baseline) investigated for associations with cigarette 
smoking (exposure) and retention in care (outcome) include age, sex, race/ethnicity, HIV 
transmission risk group, geographic region of residence, and previous or current highly 
active antiretroviral treatment (HAART).  A conceptual framework of the relationship 
between our measured covariates and the smoking and failure to be retained in care 
relationship of interest in the NA-ACCORD can be found in Figure 2.  Potential 
confounders were evaluated by determining the associations of the confounders and 
smoking status (exposure) through our analyses for Aim 1, and carefully thinking about 
the causal relationships of the confounders and retention in care (outcome). 
Age was centered on the mean age (45.71 years) and scaled by 10 years to 
improve interpretability of the coefficient.  Race/ethnicity was categorized as non-
Hispanic White, non-Hispanic Black, Hispanic, and other/unknown.  HIV transmission 
risk group was dichotomized as IDU versus non-IDU to avoid issues of collinearity 
between male sex and MSM.  For US residences, geographic region was defined by 3-
digit zip code of residence.  If residence zip code was unavailable, 3-digit zip code for the 
clinic site was used as a proxy for residence.  Geographic region for Canadian residences 
was defined by self-reported province of residence.  Geographic region of residence was 
included in analyses as a categorical variable, categorized as Southern US, outside 
Southern US, and Canada. 




HAART use was defined as a regimen of at least three antiretroviral agents 
including a protease inhibitor (PI), non-nucleoside reverse transcriptase inhibitor 
(NNRTI), fusion inhibitor (FI), or integrase inhibitor (II), or else, a triple 
nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) regimen containing abacavir 
(ABC) or tenofovir (TDF) (54).  Patients were classified as never-HAART users or ever-
HAART users at their baseline visit.  CD4 count and HIV-1 RNA viral load were defined 
using the lab data collected closest to the first visit with reported smoking status, within a 
window of 12 months prior to one month after the first visit with smoking status. HIV 
viral load and CD4⁺ T-lymphocyte (CD4) count were used to describe the population but 
were not used as potential confounders to avoid over-adjustment for HAART use (55).   
2.6 Statistical approach  
Data were analyzed using StataIC statistical software version 12.1 (StataCorp LP, 
College Station, TX).  A p-value <0.05 guided statistical interpretation. 
Missing data 
There was a low percentage of missing demographic and clinical covariate data.  
No individual had missing baseline age, sex, or prior/current HAART use status.  Less 
than 10% of individuals had missing data on HIV risk transmission group (7.34%), HIV-
1 RNA viral load at baseline (5.48%), CD4⁺ T-lymphocyte count at baseline (5.48%), 
race/ethnicity (0.20%) and region of residence (0.14%).  Due to the low numbers of 
missing covariate data, model-wise deletion was used for our analyses, which excluded 
those with missing characteristics.  
To address missing data for smoking status (exposure status), we utilized a carry-
forward approach first described in the Nurses’ Health Study assessing smoking and 




mortality among women with type-2 diabetes (56).  For any patient who was previously 
defined as never or ever smoker and failed to provide an update on smoking status during 
any visit, their smoking status was carried forward for the remainder of the visits to 
reduce the proportion with missing data. To address missing data for current smokers, the 
current smoker status was carried forward to the first visit with missing or not recorded 
smoking status data.  All subsequent missing or not recorded smoking statuses were 
replaced with the ever smoker status.   
Exploratory data analyses   
  Exploratory data analysis of the relationships between our exposures of interest 
and baseline smoking status produced significant associations.  For Aim 1, a check for 
collinearity amongst all covariates of interest confirmed correlation was not an issue, 
with the strongest correlation being between age at baseline visit of and injection drug 
use (ρ = 0.1769).   
Statistical Analyses 
Pearson’s chi-square tests for independence were used to explore the association 
between baseline smoking status and categorical demographic/HIV covariates (race, sex, 
geographic region, ever-HAART use, and HIV risk transmission group).  Likelihood ratio 
chi-square tests were used to explore the association between baseline smoking status and 
continuous demographic/HIV covariates (age, HIV-1 RNA, and CD4⁺ T-lymphocyte 
count).   
Participants were followed from baseline (defined as the first visit with reported 
smoking status and recorded laboratory data) to the last visit with recorded laboratory 
data that was < 90 days from the first visit within the calendar year (outcome) or 




administratively censored on December 31, 2010.  A graphical representation of person-
time accrual for four hypothetical patients appears in Figure 3.     
For Aim 1, participants were assigned a smoking status for the calendar years of 
2008, 2009 and 2010 as the heaviest smoking status reported for that year (current = 
heaviest).  The proportions of participants who were never, ever, and current smokers 
were estimated as the number of never, ever, and current smokers divided by the number 
of participants with an observed smoking status in that year, respectively. Trends in the 
proportions of never/ever/current smokers from 2008 to 2010 were detected using logistic 
regression models with generalized estimating equations (GEE) using independent 
correlation matrixes and robust variance estimations to account for the correlation in the 
data as an individual could contribute to each calendar year from 2008 to 2010.  
For Aim 2, the analytic goal was to isolate the effect of smoking on failing to be 
retained in HIV primary care.  In addition to drawing a conceptual framework and 
determining the associations of the confounders and smoking status (exposure) in Aim 1 
and the associations of the confounders and failing to be retained in care (outcome) in 
univariate models, forward, backward, and hierarchical stepwise selection approaches 
were considered.  Race/ethnicity, age, and IDU HIV transmission risk were included in 
the model for face validity as the relationships between these confounders and smoking 
status and retention in care were described in previous literature (4, 7, 9, 17, 20-22, 29-
35, 38, 41). 
Univariate and multivariate Cox proportional hazard models with the Efron 
method for ties were used to assess associations between time-varying smoking status 
and failing to be retained in HIV primary care over the study period.  Crude (HR) and 




adjusted (aHR) hazard ratios (HR) and 95% confidence intervals ([,]) were reported for 
each model.  The proportionality assumption in the Cox proportional hazard model was 
verified based on the Schoenfeld and scaled Schoenfeld residuals tests and review of the 
cumulative hazard plot.  Kaplan-Meier survival curves were plotted and log rank tests 
were performed to evaluate differences in survival by smoking status (Figure 4).  A check 
for collinearity amongst all variables confirmed that none were correlated; the strongest 
correlation was between smoking and IDU (ρ = -0.23). Wilcoxon-Breslow-Gehan tests 
for equality were performed to assess the equality of the survivor functions, by smoking 
status.   
Sensitivity Analyses  
Geographic region of residence was substituted with cohort to determine the 
existence of an association between cohort and failing to be retained in HIV primary care.   
Univariate and multivariate Cox proportional hazard models with the Efron method for 
ties were used to assess the crude and adjusted associations between cohort and retention 
in care.  Crude (HR) and adjusted (aHR) hazard ratios (HR) and 95% confidence 












Chapter 3. Results  
3.1 Population characteristics 
A total of 3,575 HIV-infected participants met the inclusion criteria of whom 74% 
were male, 47% were African American, 19% were IDUs, 62% resided in the Southern 
region of the U.S., and the mean (SD) age was 45.7 (9.7) years (Table 1). Of the total 
participants, 28% were current smokers at baseline who contributed 615.17 person-years, 
43% were ever smokers who contributed 776.57 person-years, and 28% were never 
smokers who contributed 631.56 person-years. 
More than half (53%) of the current smokers were African Americans but White 
participants were the majority among ever smokers (Table 1).The majority of patients 
were classified into the non-injection drug use HIV transmission group (81%).  Patients 
in the non-IDU transmission group were more likely to be ever smoking at the baseline 
visit (43%), and injection drug users (IDU) were more likely to be ever (44%) or 
currently (44%) smoking at the baseline visit.  Log(10)-transformed HIV-1 RNA viral 
load significantly differed among smoking status groups at baseline, while adjusting for 
HAART use.  Viral loads were statically significantly higher among ever and current 
smokers compared with never smokers among HAART users (p =0.0489) and never-
HAART users (p =0.0387). Median year of HAART initiation did not significantly differ 
among smoking status groups.  Median CD4⁺ T-lymphocyte count was statistically 
significantly higher among never smokers compared with ever and current smokers (483, 
463, and 445 cells/mm3, p=0.0425).    
3.2 Patterns of cigarette smoking, Aim 1 
Participants reporting current smoking status fluctuated from 31-33% in 2008, 




2009 and 2010 (p for trend <0.001, Figure 5). The proportion reporting never smoking 
status decreased from 31% in 2008 to 25% in 2009 and 26% in 2010 (p for trend <0.001).  
The proportion reporting ever smoking increased from 36% in 2008 to 44% in 2009 and 
42% in 2010 (p for trend <0.001).  The changes over time in the proportions of current, 
ever, and never smokers are relatively small (<10 percentage points) and may be 
influenced by the observation periods of each cohort (Figure 6).  For example, cohorts 1 
and 4 do not contribute in 2008, and cohort 6 does not contribute in 2010; all three of 
these cohorts have a small proportion of never smokers and a large proportion of ever 
smokers.  It is also important to note that the cohorts report large differences in the 
proportions who are current, ever and never smokers; this is not surprising as these 
cohorts differ in demographic characteristics that have been linked to smoking prevalence 
(4, 7, 9, 17, 20-22).  The observation periods for each cohort coupled with the differences 
in the smoking prevalence’s across cohorts are driving the small fluctuations in the 
overall proportions of current, ever, and never smokers. 
Regardless of age, patients were less likely to report never smoking over time and 
more likely to report ever smoker over time (Figure 7).  Patients 40 to 49 years of age had 
the largest proportions of current smokers in all three years from 36% in 2008 to 33% in 
2009 and 36% in 2010 (p for trend =0.041).  Patients 60 years of age or older had the 
largest proportions of never smokers in all three years from 43% in 2008 to 35% in 2009 
and 35% in 2010 (p for trend < 0.001).   
Female patients had a greater proportion of never smokers over time but also a 
greater proportion of currents smokers compared to males across the study period (p 
<0.001) (Figure 8).   




White, Black, and Hispanic patients were more likely to report ever smoking 
across the study period and less likely to report never smoking across the study period 
(Figure 9).  White and Black patients were also less likely to report current smoking over 
time (p for trend=0.002 & 0.004, respectively).  Black patients reported the largest 
proportion of never smokers in 2009 and 2010 with 30% and 31%, but also reported the 
largest proportion of current smokers across the study period, with 37% in 2008 to 36% 
in 2009 and 34% in 2010.  Patients with other or unknown race were less likely to report 
ever smoking over time (p for trend =0.011).  Patients with other or unknown race 
reported the largest proportion of ever smoking in 2008 and 2009 with 65% and 57%, 
respectively.   
Patients in the non-IDU transmission group were more likely to report never or 
ever smoking across the study period compared to patients in the IDU transmission group 
(p <0.001) (Figure 10).  Almost 50% of patients in the IDU transmission group reported 
currently smoking across the study period compared to 26-29% in the non-IDU 
transmission group. 
Patients residing in the Southern US had the largest proportions of current 
smokers across the study period (33-36%) compared to other regions (13-30%), however 
this proportion decreased over time (p for trend <0.001) (Figure 11).  Canadian residents 
and US residents outside of the South had larger proportions of ever smokers across the 
study period (42-81%) compared with patients from the US South (29-41%).  The 
proportion of US patients reporting never smoking decreased over time, (p for trend 
=0.001 for Outside US South & <0.001 for US South), while the proportion reporting 
ever smoking increased over time (p for trend =0.037 & <0.001, respectively).  There 




was an increasing trend in reporting currently smoking for Canadian patients across the 
study period (p for trend =0.021) and a decreasing trend in reporting ever smoking over 
time (p for trend =0.015).   
There were no differences in cigarette smoking by HAART use at baseline visit 
over the study period.   
3.3 Association between cigarette smoking and failing to be retained in HIV primary 
care, Aim 2 
A total of 2,571 patients contributed 4,072.988 person-years while under 
observation; approximately 37% (n=948) of patients were seen in all three years (2008, 
2009, 2010) of the study period. A total of 444 failures to be retained in care (outcome) 
were observed; 153, 149, and 142, among current, ever, and never smokers, respectively.  
Among all participants, 23 (0.89%) died.  
The Kaplan-Meier survival estimates and the Wilcoxon-Breslow-Gehan tests for 
survival function equality, by smoking status can be seen in Figure 4.  There was a 
greater number of events observed than expected among never and current smokers and a 
lesser number of observed events than expected among ever smokers.  Never, ever, and 
current smokers have differing probabilities of retention in care over the study period (p 
=0.0168).  Patients identified as never, ever, and current smokers followed a similar trend 
in failure across calendar time (Figure 12).  Regardless of smoking status, patients had an 
increasing probability of failing to be retained in care in the first and fourth quarters of 
2009 and 2010 (Jan-Mar & Oct-Dec).  Probability of failing to be retained in care 
decreased in the second and third quarters of 2009 and 2010 (Apr-Sept).  The Schoenfeld 
and scaled Schoenfeld residual test failed to find a violation of the proportional hazards 




assumption in our multivariate models (p =0.4225). 
In crude (univariate) models, ever smokers had a 27% decrease in the risk of 
failing to be retained in care compared to never smokers (HR=0.73 [0.58, 0.92]), but 
there was no relationship between current vs. never smokers on failing to be retained in 
care.  Blacks (compared with Whites HR=1.66 [1.36, 2.02)]) IDUs (compared with non-
IDU HR=1.71 [1.37, 2.15]), and Southern US residents (compared with outside the 
Southern US HR=3.78 [2.21, 6.46]) all had statistically significant increases in the risk of 
failing to be retained in care; Canadians had a reduced risk of failing to be retained in 
care compared to those residing in the US outside of the South (HR=0.48 [0.23, 1.00]).  
Age (scaled by 10 years and centered on sample average age) had a statistically 
significant decrease in the risk of failing to be retained in care; (HR=0.90 [0.82, 0.99]).  
There was no crude association of sex or HAART use and failing to be retained in care. 
In multivariate models that adjusted for age, race/ethnicity, IDU status, 
geographic region of residence, HAART use, the statistically significant decrease in the 
risk of failing to be retained in care among ever compared with never smokers remained 
(aHR=0.64 [0.50, 0.81]); the lack of an association between current smokers (vs. never) 
and failing to be retained in care persisted (aHR=0.92 [0.73, 1.17]).  Age (scaled by 10 
years and centered on sample average age) (vs. average age aHR=0.83 [0.75, 0.92]), IDU 
(vs. non-IDU aHR=1.36 [1.06, 1.74]), and geographic region (US South vs. outside US 
South aHR=2.10 [1.19, 3.69]; Canada vs. outside US South aHR=0.32 [0.15, 0.68]) 
relationships with failing to be retained in care persisted (Table 2). There were no 
statistically significant or meaningful differences between sex, race/ethnicity or HAART 
use and failing to be retained in care in the multivariate models (Figure 13). 




 In a sensitivity analysis of the crude (univariate) model for retention in care by 
cohort, patients in Cohort 2 and Cohort 6 (vs. Cohort 1) had statistically significant 
increases in the risk of failing to be retained in care (HR=10.15 [2.52, 40.80] & HR=5.80 
[1.27, 26.52]).  In the multivariate model, substituting cohort for geographic region of 
residence, the decrease in the risk of failing to be retained in care among ever compared 
with never smokers was no longer statistically significant (aHR=0.96 [0.74, 1.25]; the 
lack of an association between current smokers (vs. never) and failing to be retained in 
care persisted (aHR=0.99 [0.78, 1.26]) (Table 3).  The statistically significant decrease in 
risk of failing to be retained in care by age persisted (aHR=0.79 [0.71, 0.87]).   The 
cohort relationship with failing to be retained in care persisted (Cohort 2 vs. Cohort 1 
aHR=11.49 [2.78, 47.53]; Cohort 6 vs. Cohort 1 aHR=5.79 [1.24, 26.92]).  There were no 
statistically significant or meaningful differences between sex, race/ethnicity, IDUs, or 
HAART use and failing to be retained in care in the sensitivity analysis of the 














Chapter 4: Discussion and Conclusion 
4.1 Discussion 
In a large, clinical cohort collaboration of HIV-infected persons from the NA-
ACCORD, 70-75% of adults reported current or ever smoking, as compared to the 
general population in the United States and Canada where smoking prevalence is 
estimated to be 19.3 % and 16.7%, respectively (57 & 58).  Among HIV-infected adults, 
annual prevalence of current and ever smokers differed by age, race/ethnicity, sex, IDU 
status, and region from 2008-2010. Ever smokers had a decrease in the risk of failing to 
be retained in care compared to never smokers, after adjusting for demographics and 
HAART use. Current smokers had an increased risk of failing to be retained in care 
compared to ever smokers, after adjusting for demographics and HAART use. 
Patterns in smoking among HIV-infected adults, 2008-2010 
There were interesting patterns of smoking by age, sex, race/ethnicity, IDU status 
and geography. Middle-aged patients (40-49 and 50-59 year olds) reported the highest 
proportions of current smokers.  As expected, older patients (60+ year olds) reported the 
highest proportion of never smokers; this is likely a survival bias. Studies in the general 
population and in HIV-infected adults show that age is a strong predictor of smoking 
status (7 & 20).  Because people with HIV are living longer (59) and are thought to be at 
higher risk for age-related comorbidities (2, 4, 12-14) that are also influenced by 
smoking, smoking cessation programs are urgently needed and should be targeted to 
middle and younger ages. 
Women had slightly higher proportions who were never smokers compared to 
men in all three years examined, however, they also had greater proportions who were 




current smokers. This may reflect that the age distribution among women is concentrated 
in the middle-ages where current smoking prevalence is highest. Similar to patterns seen 
in women, Black adults had higher proportions of current and never smoking in all three 
years compared to White adults; these results are likely reflecting that the age distribution 
among Black adults is concentrated in the middle-ages where current smoking prevalence 
is highest. As expected, IDUs had highest proportions of current smokers in all three 
years, ranging from 46-51%.  Finally, the US South had the highest proportion of current 
smokers, but also the highest proportion of never smokers; these results are likely 
reflecting that the age distribution among Southern US adults is concentrated in the 
middle-ages where current smoking prevalence is highest.  These patterns demonstrate 
the need for targeted smoking cessation interventions among middle-aged, female, Black, 
IDU adults and those that reside in the Southern US.  Further studies looking at the 
smoking prevalence in combined demographic categories, like Black women residing in 
the Southern US, are needed. 
The association of smoking status on retention in care 
At first, the findings seem counter-intuitive: why would ever smoking (vs. never 
smoking) reduce the risk of failing to be retained in care? Prior research suggests that 
HIV-infected individuals who do not smoke have less HIV-associated and non-HIV 
associated infections than those with smoking history (4, 7, 9, 17, 20-22), signaling that 
those who do not smoke are healthier than current smokers.  Additionally, it has been 
shown that having a chronic medical comorbidity is associated with improved retention 
in HIV care (30). HIV-infected adults who were ever smokers may require a greater 
number of clinic visits due to their increase risk of chronic conditions and have greater 




retention in care due to the need to treat their chronic conditions.  
Our findings did not show an association between never smoking and current 
smoking and failing to be retained in care. Although we expected to see an increase in the 
risk of failing to be retained in care among current compared with never smokers, it may 
be that there is a “healthy current smoker” effect.  Smokers that have negative health 
effects from smoking may be more likely to quit, but current smokers may be more likely 
to continue smoking without immediately identified negative health effects. Those that 
reported currently smoking may be healthier than ever smokers, may tend to smoke with 
less frequency, and may have shorter smoking history compared to ever smokers; 
resulting in less encouragement from their medical providers to quit or reduce their 
smoking consumption.   Further, if smokers feel similar in health to never smokers, their 
retention in care may be similar, resulting in no difference in the risk of failing to be 
retained in care comparing current with never smokers, as our results show.  This time-
dependent confounding of perceived health status on the relationship of smoking on 
failing to be retained in care was not taken into account in our analyses as the NA-
ACCORD participants do not have a measure of perceived health status. 
We are limited to speculation on the effects of smoking duration, and smoking 
frequency on retention in care in our sample, due to a lack of comprehensive quantitative 
data on smoking history.  Future research may focus on assessing the relationship 
between retention in HIV primary care and quantitative data on smoking consumption, 
such as pack-years.   
The association of covariates on retention in care 
 Although our research question focused on the relationship of smoking and 




retention in HIV care, multivariate analyses showed interesting relationships of identified 
confounders with retention in HIV care.   In our study, the unadjusted risk of failing to be 
retained in care was higher for Black (vs. White) and IDU (vs. non-IDU) participants, 
and for those living in the Southern US (vs. outside the Southern US).  The racial 
differences did not persist in adjusted models, but the increased risk of failing to be 
retained in care among IDUs and those living in the southern US remained.  The risk of 
failing to be retained in care decreased with increasing age and was lower among 
Canadians compared to those residing in the Southern US in crude and adjusted models. 
 The association between IDU and poor retention has been previously 
demonstrated, as has the decreased likelihood of failing to be retained in HIV care with 
increasing age (29-35, 38, 41).    
The crude relationship showing an increased risk of failing to be retained in care 
among Black, compared with White, participants diminishes to a null relationship in the 
adjusted model, likely due to the inclusion of geographic region of residence in the 
adjusted model.  Previous studies have also demonstrated the increased risk of failing to 
be retained in HIV care among Black adults, however, these studies did not adjust for 
geographic region (29-31, 34). The disappearance of race/ethnicity as a significant factor 
in failing to be retained in care once we adjusted for region of residence suggests that 
disparities in retention by race/ethnicity are possibly due to a geographic effect.           
Geographic region of residence had the strongest association of failing to be 
retained in HIV care in our crude and adjusted models. Geographic region of residence 
may serve as a proxy for a number of regional differences related to the acceptance of 
HIV status and openness to initiating and maintaining routine HIV primary care.  HIV-




infected individuals have been found to be less likely to maintain routine HIV care when 
they disclose their HIV status to less social network members (60) and when they are in 
need of stable housing (61).  Regional differences may exist in the stigma of being HIV-
positive, safe sexual practices, average socioeconomic status (SES) and percentage of 
individuals with employment-provided health insurance, access to public transportation, 
average car usage, urban sprawl and geographic dispersion of neighborhoods, and 
varying office hours or scheduling practices by clinics.   
In our sensitivity analyses, we substituted cohort for geographic region of 
residence in the crude and adjusted models. Cohort had the strongest association of 
failing to be retained in HIV care in our crude and adjusted models, supporting the 
geographic effect of disparities in retention.  After adjusting for cohort, we failed to find 
previous differences in risks of failing to be retained in care by smoking and IDU in our 
adjusted model.  The decreased risk of failing to be retained in care with increasing age 
remained in our adjusted model, controlling for cohort.  
Finally, there was no difference in the risk of failing to be retained in care by sex 
or HAART use. Sex has not previously been shown to be a strong predictor of retention 
in HIV care (30, 35, & 41).  Previous studies have demonstrated those who are using 
HAART are more likely to be retained in care (30).  It is possible that this relationship 
was not demonstrated in our data because 69% of participants were using HAART at 
baseline of our study.  This high proportion using HAART is reflective of HIV-infected 
adults in clinical care in the US.  
4.2 Limitations 
Our main limitation was our inability to determine current from ever smokers.  




Some ever smokers may be current smokers, however, some of the smoking status data 
were collected in such a way that only ever/never smoking status was obtained. It is 
likely that some of the current smokers are classified as ever smokers. Correcting this 
misclassification may result in an increased risk of failure to be retained in care in current 
smokers and an even stronger protective effect of ever smoking.  There was also limited 
data regarding the quantity and duration of smoking, such as pack-years.  
There may be differences in acceptability of smoking by region.  Smokers who 
live in regions with more limitations on smoking in public spaces or less access to 
cigarettes in convenience stores may be more likely to underestimate their smoking 
history or may be more likely to oscillate between currently smoking and attempting to 
quit due to increased social stigma.  These oscillations may not have been accurately 
captured by our carry forward and carry backward approaches to address missing 
smoking data. 
Additionally, we were unable to account for duration of time since HIV diagnosis, 
as these data are unavailable in the NA-ACCORD.  Failing to be retained in HIV primary 
care during the first year following an HIV diagnosis is associated with adverse HIV-
related outcomes and increased long-term mortality (28).  Patients identifying as current 
smokers within their first year following an HIV diagnosis may be particularly at risk for 
failing to be retained in care.  Identifying these individuals and linking them with routing 
HIV care and smoking cessation programs may play a critical role in decreasing HIV-
related comorbidities and long-term mortality.    
Finally, the NA-ACCORD has been shown to be reflective of persons living with 
HIV in the U.S. (62), however, our study is nested in a sub-sample of 5 NA-ACCORD 




clinical cohorts that contributed smoking and HIV primary care visit data; 
generalizability of our findings may be questionable. Our study population (Table 1) has 
similar demographic characteristics to people living with HIV/AIDS in the US as of 2011 
(64).  
4.3 Future Analyses 
 Future analyses of the effect of smoking on retention in care should take into 
account: 
 The time-dependent confounding of preceded health status on smoking and 
retention in HIV clinical care using marginal structural models 
 The confounding effects of additional social factors on the smoking and retention 
in HIV care relationship using proportional hazards mixed effects models to 
adjusting for regional characteristics of HIV stigma, availability of public 
transportation, urban sprawl, clinic operating practices, median household income 
of the census block of residence, and patterns of safe sexual practices.   
Regional differences in the proportion of convenience stores that sell cigarettes and 
the percentage of public spaces that are “smoke-free” could also be assessed.  Mixed 
effects models appropriately account for clustered survival times of individuals within the 
same region and would be able to assess whether a larger proportion of the variance in 
retention duration is found between regions rather than within regions.  Furthermore, 
mixed effects models can provide more specific recommendations on the level of 
government to be responsible for targeting smoking cessation services to HIV-infected 
individuals.  If there is a larger discrepancy in retention duration between regions rather 
than within regions, then channeling national funds to increase tobacco cessation services 




for HIV-infected individuals across the country would be more efficient at reducing the 
hazard of failing to be retained in care among smokers.   
4.4 Conclusion 
Our findings of the patterns in smoking in HIV-infected adults and the 
relationship between smoking and retention in HIV care are an important first step in 
generating ideas for policies and programs to reduce smoking prevalence and increase 
retention in HIV clinical care in the U.S. and Canada.  Programs incorporating smoking 
cessation into HIV clinical care may help better retain current smokers who are trying to 
quit.  With a prevalence approximately 30% current smokers in this HIV-infected 
population with access to HIV clinical care, increasing funding of highly accessible and 
effective smoking cessation programs may result in better health outcomes and progress 



















N =            3,575 N = 1,013           N =            1,554 N =               1,008 
Person-Years, % 615.17 30% 776.57 38% 631.56 31%
Age (years), mean (+/- SD) 0.6261
Sex <0.001
Female 923 26%       289 29%       307 20%      327 32%
Male 2652 74%       724 71%    1,247 80%      681 68%
Race/Ethnicity <0.001
White   1,583 44%       404 40%       813 52%      366 36%
Black   1,677 47%       536 53%       579 37%      562 56%
Hispanic      102 3%         22 2%         49 3%        31 3%
Other/Unknown      213 6%         51 5%       113 7%        49 5%
HIV Transmission Groupᵈ <0.001
Non-IDU 2895 81% 713 70% 1257 81% 925 92%
IDU 680 19%       300 30%       297 19%        83 8%
Geographic Regionᵉ <0.001
United States Northeast 11 0%           3 0%           2 0%          6 1%
South 2220 62%       694 69%       832 54%      694 69%
West 443 12%         65 6%       321 21%        57 6%
Canada Alberta 493 14%       189 19%         81 5%      223 22%
British Columbia 3 0%           2 0%          -   0%          1 0%
Ontario 395 11%         59 6%       310 20%        26 3%
Quebec 3 0%          -   0%           3 0%         -   0%
Saskatchewan 2 0%           1 0%          -   0%          1 0%
Missing 5 0%          -   0%           5 0%         -   0%
Year of HAART Initiation, median (IQR) 0.816
HIV-1 RNAᶠ, median (IQR) Ever-HAART Users 0.0489
Never-HAART Users 0.0387
Missing      196 5%         77 8%         65 4%        54 5%
CD4⁺ T-Lymphocyte Count, median cells/mm³ (IQR) 0.0425
Missing      196 5%         77 8%         65 4%        54 5%
SD Standard deviation
IQR Interquartile range
MSM Men who have sex with men
IDU Injection drug users
ᵃCharacteristics measured at baseline, defined as first visit with reported smoking status and lab data. 
ᵇSmoking status defined as never if no prior history of smoking, ever if prior history of smoking but not currently smoking, current if currently smoking at baseline.
ᶜFor categorical variables, p-values are for Pearson's chi-square tests for independence, significance at p<0.05. For continuous variables, p-values are for likelihood ratio chi-square tests, significance at p<0.05. 
ᵈIf a person reported both MSM and IDU, person was classified as IDU.
ᵉRegion was defined by 3-digit zip code of residence and categorized by Census Bureau-designated regions.  If residence zip code was unavailable, 3-digit zip code for clinic was used as a proxy for residence. 
ᶠHIV-1 RNA was log(10)-transformed.
 445 (262, 658) 
Ever Smokers
45.70 (9.71)
 2005 (2001, 2008) 
 3.91 (3.91, 4.88) 
 5.38 (3.91, 9.25) 






 4.32 (3.91, 8.87) 
463 (302, 658)
Table 1. Characteristicᵃ comparisons of 3,575 HIV-infected persons, stratified by smoking statusᵇ, 2008-2010.
Never Smokers
 483 (330, 650) 
 3.91 (3.91, 4.32) 
 4.17 (3.91, 8.25) 
44.95 (10.41)
 2004 (2001, 2008) 
 463 (301, 658) 
Current Smokers
45.98 (8.78)
 2005 (2001, 2008) 
 3.91 (3.91, 4.71) 







Table 2. Univariate and multivariate analyses of characteristicsᵃ and time-varying smoking status predictive of failing to be retained in HIV primary careᵇ.
Smokingᵉ
Never
Ever (0.58, 0.92) (0.50, 0.81)
Current (0.86, 1.36) (0.73, 1.17)
Age (years)ᶠ (0.82, 0.99) (0.75, 0.92)
Sex
Male
Female (0.97, 1.46) (0.80, 1.21)
Race/Ethnicity
White
Black (1.36, 2.02) (0.81, 1.25)
Hispanic (0.40, 1.54) (0.47, 1.87)
Other/Unknown (0.21, 1.08) (0.40, 2.10)
HIV Transmission Groupᵍ
Non-IDU
IDU (1.37, 2.15) (1.06, 1.74)
Geographic Regionʰ
Outside of Southern US
Southern US (2.21, 6.46) (1.19, 3.69)
Canada (0.23, 1.00) (0.15, 0.68)
HAART Use
Never-HAART Users
Ever-HAART Users (0.69, 1.08) (0.74, 1.16)
IDU Injection drug users
CI Confidence Interval
ᵃCharacteristics, apart from smoking, were measured at baseline, defined as first visit with reported smoking status and lab data. 
ᵇFailing to be retained was defined as time to first occurrence when the Institute of Medicine retention in care measure was not met. 
ᶜCrude hazard ratios are for univariate Cox proportional hazard models.
ᵈAdjusted hazard ratios are for multivariate Cox proportional hazard models adjusted for all variables in the table and cohort.
ᵉSmoking was time-varying across the study period.
ᶠAge was centered at the sample mean age (45.71 years) and scaled by 10 years
ᵍHIV risk was dichotomized as IDU vs. non-IDU to avoid issues of collinearity between male sex and MSM.
ʰGeographic region was categorized as US South, non-US South, and Canada due to the majority of the sample residing in US South (62.10%).





































Table 3. Univariate and multivariate analyses of characteristicsᵃ and time-varying smoking status predictive of failing to be retained in HIV primary careᵇ (sensitivity analysis).
Smokingᵉ
Never
Ever (0.58, 0.92) (0.74, 1.25)
Current (0.86, 1.36) (0.78, 1.26)
Age (years)ᶠ (0.82, 0.99) (0.71, 0.87)
Sex
Male
Female (0.97, 1.46) (0.72, 1.10)
Race/Ethnicity
White
Black (1.36, 2.02) (0.70, 1.09)
Hispanic (0.40, 1.54) (0.44, 1.77)
Other/Unknown (0.21, 1.08) (0.35, 1.87)
HIV Transmission Groupᵍ
Non-IDU
IDU (1.37, 2.15) (0.78, 1.29)
Cohortʰ
Cohort 1
Cohort 2 (2.52, 40.80) (2.78, 47.53)
Cohort 4 (0.27, 5.11) (0.26, 5.22)
Cohort 5 (0.98, 16.20) (0.95, 16.44)
Cohort 6 (1.27, 26.52) (1.24, 26.92)
HAART Use
Never-HAART Users
Ever-HAART Users (0.69, 1.08) (0.82, 1.28)
IDU Injection drug users
CI Confidence Interval
ᵃCharacteristics, apart from smoking, were measured at baseline, defined as first visit with reported smoking status and lab data. 
ᵇFailing to be retained was defined as time to first occurrence when the Institute of Medicine retention in care measure was not met. 
ᶜCrude hazard ratios are for univariate Cox proportional hazard models.
ᵈAdjusted hazard ratios are for multivariate Cox proportional hazard models adjusted for all variables in the table and cohort.
ᵉSmoking was time-varying across the study period.
ᶠAge was centered at the sample mean age (45.71 years) and scaled by 10 years
ᵍHIV risk was dichotomized as IDU vs. non-IDU to avoid issues of collinearity between male sex and MSM.
ʰCohort 3 failed to provide HIV primary care data and was excluded from analyses.
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Figure 4. Kaplan-Meier survival estimates (S(t)) of being retained in HIV primary care, by smoking status (2008-2010).  
 













































Jan 2009 Jun 2009 Jan 2010 Jun 2010 Jan 2011
Calendar Year
Never Smoking Ever Smoking
Current Smoking
Events Observed Events Expected Sum of ranks
Never Smoking 142 130.5 18327
Ever Smoking 149 178.52 -47497
Current Smoking 153 134.97 29170








Figure 5. Distribution of patients’ smoking status, by response year (2008-2010).* 
 








































































2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010
Cohort 1 Cohort 2 Cohort 3 Cohort 4 Cohort 5 Cohort 6
Never Ever Current
0.001* 0.033* 0.337* 0.069* <0.001* 0.008*
0.141* 0.016* 0.845* 0.291* <0.001* 0.049*
0.826* 0.374* 0.564* 0.281* 0.757* 0.944*
N = 74 N = 104 N = 1388 N = 1329 N = 1142 N = 201 N = 374 N = 357 N = 325 N = 494 N = 259 N = 630 N = 774 N = 110 N = 330






Figure 7. Distribution of patients’ smoking status, by age and year (2008-2010).   
 









































2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010
<30 Years of Age 30-39 Years of Age 40-49 Years of Age 50-59 Years of Age 60 + Years of Age
Never Ever Current
0.003* <0.001* <0.001* <0.001* <0.001*
0.001* <0.001* <0.001* <0.001* <0.001*
0.232* 0.486* 0.041* 0.004* 0.230*
N = 106 N = 193N = 195 N = 125 N = 682 N = 746N = 521 N = 1183 N = 1293 N = 833 N = 615 N = 631 N = 373 N = 198 N = 197 































2008 2009 2010 2008 2009 2010
Male Female
Never Ever Current
N = 2,099 IndividualsN = 2,262 IndividualsN = 1,361 Individuals N = 597 Individuals N = 800 Individuals N = 772 Individuals





















































2008 2009 2010 2008 2009 2010 2008 2009 2010 2008 2009 2010
White Black Hispanic Other or Unknown
Never Ever Current
N = 642 
Individuals
N = 1347 
Individuals
N = 1246 
Individuals
N = 1222 
Individuals
N = 1457 
Individuals
N = 1370 
Individuals
N = 26 
Individuals
N = 76 
Individuals
N = 81 
Individuals
N = 66 
Individuals
N = 178 
Individuals
N = 169 
Individuals
*P-values are for univariate GEE tests for trend in time-varying smoking status  with robust variance estimations and an independent working correlation matrix.
<0.001* <0.001* 0.010* 0.447*
<0.001* <0.001* 0.011* 0.011*











* Patients’ smoking status was categorized as the heaviest smoking status reported in that year (current = heaviest). 
 

















2008 2009 2010 2008 2009 2010
Non-IDU IDU
Never Ever Current
N = 2,416 IndividualsN = 2,431 IndividualsN = 1,425 Individuals N = 533 Individuals N = 631 Individuals N = 455 Individuals






Figure 11. Distribution of patients’ smoking status, by geographic region of residence and year (2008-2010). 
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Figure 13. Forest plot of multivariate Cox proportional hazard model for failing to be retained in HIV primary care over time 
(2008-2010). 
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Figure 14. Forest plot of multivariate Cox proportional hazard model for failing to be retained in HIV primary care over time, 
substituting cohort for geographic region of residence (2008-2010). 
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